Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Hind T Hatoum"'
Publikováno v:
Epilepsia Open, Vol 8, Iss 4, Pp 1556-1565 (2023)
Abstract Objective To gather real‐world evidence on antiseizure medications (ASMs) treatment patterns and related outcomes in patients with drug‐resistant focal epilepsy. Methods Medical insurance claims from the start of 2014 till the end of 201
Externí odkaz:
https://doaj.org/article/9817153df6484684ae98470e11e1a34e
Autor:
Jennifer L. Miller, Moris Angulo, Richard Willey, Elisabeth M. Dykens, Elizabeth Roof, Guy Bolton, Hind T. Hatoum, Paul Korner, Michael Reidy
Publikováno v:
JCI Insight. 3
BACKGROUND. Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder of life-threatening hyperphagia, obesity, intellectual deficits, compulsivity, and other behavioral problems. The efficacy and safety of i.n. carbetocin, an oxytocin ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2759c44d8fb6157bb2b81ce34b39f86
https://doi.org/10.1172/jci.insight.98333
https://doi.org/10.1172/jci.insight.98333
Publikováno v:
Journal of Medical Economics. 17:326-337
To determine the cost-effectiveness of bioengineered hyaluronic acid (BioHA, 1% sodium hyaluronate) intra-articular injections in treating osteoarthritis knee pain in poor responders to conventional care (CC) including non-steroidal anti-inflammatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b7726bee0b65aa0987ea6fc7962f60
https://doi.org/10.3111/13696998.2014.902843
https://doi.org/10.3111/13696998.2014.902843
Publikováno v:
Postgraduate Medicine. 126:65-75
Febuxostat is recommended as 1 of 2 first-line urate-lowering therapies (ULT) for treating gout in the 2012 American College of Rheumatology Guidelines. Several efficacy trials have compared febuxostat with allopurinol treatment, but real-world compa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c5e91ac33d61c3c6f95e147638ff36a
https://doi.org/10.3810/pgm.2014.03.2741
https://doi.org/10.3810/pgm.2014.03.2741
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 13:261-270
Degarelix, approved in the USA in 2008, is a gonadotropin-releasing hormone antagonist, representing one of the latest additions to androgen deprivation therapy (ADT). ADT is used as first-line therapy for locally advanced or metastatic prostate canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bde61452ab6af053abee6617360eaf2e
https://doi.org/10.1586/erp.13.13
https://doi.org/10.1586/erp.13.13
Autor:
Hind T Hatoum, John G Fort
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 9
Background: Improvements in antiplatelet strategies could have a significant impact on cardiovascular (CV) events. PA32540 is a novel single-dose tablet of 325 mg enteric-coated aspirin and 40 mg immediate-release omeprazole developed to significantl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7b1cce3dd8582637a76e8127e870cc4
https://doi.org/10.1161/circoutcomes.9.suppl_2.124
https://doi.org/10.1161/circoutcomes.9.suppl_2.124
Publikováno v:
International journal of clinical pharmacy. 39(1)
Background The Middle East region has one the highest prevalence rates of diabetes in the world. Little is known about the determinants of adherence and the role of knowledge in diabetes self-management within these populations. Objective To investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1e3e6012782b23aeb4ee5d8b25af34
https://pubmed.ncbi.nlm.nih.gov/27878750
https://pubmed.ncbi.nlm.nih.gov/27878750
Publikováno v:
Current Medical Research and Opinion. 27:1255-1262
The purpose of this study is to describe patterns of hypomethylating agents (HMA) use and to compare treatment outcomes of decitabine (DAC) and azacitidine (AZA) with respect to transfusion dependence and the use of erythropoiesis-stimulating agents
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7614439a703322c148647f811952d9bb
https://doi.org/10.1185/03007995.2011.576236
https://doi.org/10.1185/03007995.2011.576236
Publikováno v:
Supportive Care in Cancer
Purpose The aim of this study was to compare the risk of chemotherapy-induced nausea and vomiting (CINV) events for various 5-HT3 RAs in patients who received moderately (MEC) or highly emetogenic chemotherapy (HEC) by evaluating hospital or emergenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf3a657df7c30676daa798c51fe808b
https://doi.org/10.1007/s00520-011-1165-1
https://doi.org/10.1007/s00520-011-1165-1
Publikováno v:
Seminars in Arthritis and Rheumatism. 39:1-9
To report the FLEXX trial, the first well-controlled study assessing the safety and efficacy of Euflexxa (1% sodium hyaluronate; IA-BioHA) therapy for knee osteoarthritis (OA) at 26 weeks.This was a randomized, double-blind, multicenter, saline-contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1406f454a46cb3ff162aa76337c926
https://doi.org/10.1016/j.semarthrit.2009.04.001
https://doi.org/10.1016/j.semarthrit.2009.04.001